Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Almond

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Lancet. Child & Adolescent Health|September 21, 2020
A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi processRachel Harwood, Benjamin Allin, Christine E Jones, et al.
Neurochemical Research|June 8, 2023
Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for SchizophreniaRosa Fradley, Pascal Goetghebeur, David Miller, et al.
Neurochemical Research|July 13, 2023
Correction to: Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for SchizophreniaRosa Fradley, Pascal Goetghebeur, David Miller, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2008
The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitorsTim Sparey, Pravien Abeywickrema, Sarah Almond, et al.
ACS Medicinal Chemistry Letters|April 20, 2023
Discovery of <b>CVN636</b>: A Highly Potent, Selective, and CNS Penetrant mGluR<sub>7</sub> Allosteric AgonistLouise Dickson, Martin Teall, Elodie Chevalier, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1Wesley P Blackaby, Richard T Lewis, Joanne L Thomson, et al.
Nature Communications|November 13, 2023
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse modelTracy-Shi Zhang Fang, Yu Sun, Andrew C Pearce, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Lancet. Child & Adolescent Health|September 21, 2020
A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi processRachel Harwood, Benjamin Allin, Christine E Jones, et al.
Neurochemical Research|June 8, 2023
Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for SchizophreniaRosa Fradley, Pascal Goetghebeur, David Miller, et al.
Neurochemical Research|July 13, 2023
Correction to: Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for SchizophreniaRosa Fradley, Pascal Goetghebeur, David Miller, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2008
The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitorsTim Sparey, Pravien Abeywickrema, Sarah Almond, et al.
ACS Medicinal Chemistry Letters|April 20, 2023
Discovery of <b>CVN636</b>: A Highly Potent, Selective, and CNS Penetrant mGluR<sub>7</sub> Allosteric AgonistLouise Dickson, Martin Teall, Elodie Chevalier, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1Wesley P Blackaby, Richard T Lewis, Joanne L Thomson, et al.
Nature Communications|November 13, 2023
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse modelTracy-Shi Zhang Fang, Yu Sun, Andrew C Pearce, et al.
Pageof 2